318 related articles for article (PubMed ID: 29476764)
1. Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides.
Boslett J; Helal M; Chini E; Zweier JL
J Mol Cell Cardiol; 2018 May; 118():81-94. PubMed ID: 29476764
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CD38 in the major cell types of the heart: endothelial cells highly express CD38 with activation by hypoxia-reoxygenation triggering NAD(P)H depletion.
Boslett J; Hemann C; Christofi FL; Zweier JL
Am J Physiol Cell Physiol; 2018 Mar; 314(3):C297-C309. PubMed ID: 29187364
[TBL] [Abstract][Full Text] [Related]
3. Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart.
Reyes LA; Boslett J; Varadharaj S; De Pascali F; Hemann C; Druhan LJ; Ambrosio G; El-Mahdy M; Zweier JL
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11648-53. PubMed ID: 26297248
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury.
Boslett J; Reddy N; Alzarie YA; Zweier JL
J Pharmacol Exp Ther; 2019 Apr; 369(1):55-64. PubMed ID: 30635470
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
6. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
Inserte J; Hernando V; Vilardosa Ú; Abad E; Poncelas-Nozal M; Garcia-Dorado D
J Am Heart Assoc; 2013 Jan; 2(1):e005975. PubMed ID: 23525447
[TBL] [Abstract][Full Text] [Related]
7. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
8. Luteolinidin Protects the Postischemic Heart through CD38 Inhibition with Preservation of NAD(P)(H).
Boslett J; Hemann C; Zhao YJ; Lee HC; Zweier JL
J Pharmacol Exp Ther; 2017 Apr; 361(1):99-108. PubMed ID: 28108596
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell-specific roles for tetrahydrobiopterin in myocardial function, cardiac hypertrophy, and response to myocardial ischemia-reperfusion injury.
Chuaiphichai S; Chu SM; Carnicer R; Kelly M; Bendall JK; Simon JN; Douglas G; Crabtree MJ; Casadei B; Channon KM
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H430-H442. PubMed ID: 36735402
[TBL] [Abstract][Full Text] [Related]
10. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
Pozo-Navas B; Stessel H; Wölkart G; Brunner F
J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
Brunner F; Maier R; Andrew P; Wölkart G; Zechner R; Mayer B
Cardiovasc Res; 2003 Jan; 57(1):55-62. PubMed ID: 12504814
[TBL] [Abstract][Full Text] [Related]
12. Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection.
Xie L; Talukder MA; Sun J; Varadharaj S; Zweier JL
J Mol Cell Cardiol; 2015 Sep; 86():14-22. PubMed ID: 26116866
[TBL] [Abstract][Full Text] [Related]
13. Survival kinase-dependent pathways contribute to gender difference in the response to myocardial ischemia-reperfusion and ischemic post-conditioning.
Ciocci Pardo A; Scuri S; González Arbeláez LF; Caldiz C; Fantinelli J; Mosca SM
Cardiovasc Pathol; 2018; 33():19-26. PubMed ID: 29414428
[TBL] [Abstract][Full Text] [Related]
14. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice.
Flögel U; Decking UK; Gödecke A; Schrader J
J Mol Cell Cardiol; 1999 Apr; 31(4):827-36. PubMed ID: 10329210
[TBL] [Abstract][Full Text] [Related]
15. Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats.
An J; Du J; Wei N; Xu H; Pritchard KA; Shi Y
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1783-91. PubMed ID: 19717731
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.
Wang L; Quan N; Sun W; Chen X; Cates C; Rousselle T; Zhou X; Zhao X; Li J
Cardiovasc Res; 2018 May; 114(6):805-821. PubMed ID: 29409011
[TBL] [Abstract][Full Text] [Related]
17. Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury.
Leucker TM; Ge ZD; Procknow J; Liu Y; Shi Y; Bienengraeber M; Warltier DC; Kersten JR
PLoS One; 2013; 8(7):e70088. PubMed ID: 23894596
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
[TBL] [Abstract][Full Text] [Related]
19. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
Pernow J; Wang QD
Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551
[TBL] [Abstract][Full Text] [Related]
20. Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.
Zhang R; Fang W; Han D; Sha L; Wei J; Liu L; Li Y
Planta Med; 2013 Sep; 79(14):1289-97. PubMed ID: 23929248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
